Clinical Trial Update: BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Fluticasone Propionate/Salmeterol Inhalation Powder in bronchial asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Asthma

Drugs mentioned

• Fluticasone Propionate/Salmeterol Inhalation Powder (fluticasone propionate/salmeterol inhalation powder)

Snippet

Sponsor: Cipla Ltd. | Conditions: Bronchial Asthma | Phase 3 | Status: COMPLETED